SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026054
Filing Date
2021-05-10
Accepted
2021-05-10 16:11:14
Documents
72
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rvmd-10q_20210331.htm 10-Q 2554477
2 EX-31.1 rvmd-ex311_7.htm EX-31.1 21483
3 EX-31.2 rvmd-ex312_9.htm EX-31.2 21660
4 EX-32.1 rvmd-ex321_8.htm EX-32.1 8484
5 EX-32.2 rvmd-ex322_6.htm EX-32.2 8542
  Complete submission text file 0001564590-21-026054.txt   8784956

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rvmd-20210331.xml EX-101.INS 1994344
7 XBRL TAXONOMY EXTENSION SCHEMA rvmd-20210331.xsd EX-101.SCH 58875
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rvmd-20210331_cal.xml EX-101.CAL 59561
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvmd-20210331_def.xml EX-101.DEF 179484
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmd-20210331_lab.xml EX-101.LAB 452893
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmd-20210331_pre.xml EX-101.PRE 335888
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39219 | Film No.: 21907275
SIC: 2836 Biological Products, (No Diagnostic Substances)